Welcome to the e-CCO Library!

P320 Thrombocytosis in acute inflammatory bowel disease: a useful biomarker?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. Gazelakis1, I. Chu1, C. Martin2, M. Ward1,3, M. Sparrow1,3

Created: Thursday, 30 January 2020, 10:12 AM
P320: 6-Thioguanine nucleotide levels are associated with trough levels of infliximab and adalimumab in Inflammatory Bowel Disease patients on combination therapy: A retrospective multicentre study
Year: 2022
Source: ECCO'22
Authors: Yu, N.(1);Tassone, D.(1);Lee, T.(1);Phan, S.(2);Wu, D.M.(2);Tjahyadi, J.(3);Dutt, K.(3);Liou, H.(4);Wang, L.(5);Zhang, J.(6);Basnayake, C.(1,7);Wright, E.(1,7);Lust, M.(1);Niewiadomski, O.(1);Kamm, M.A.(1,7);Connell, W.(1);Thompson, A.(1,7);Hilmi, I.(8);Affendi Raja Ali, R.(9);Wei, S.C.(4);De Cruz, P.(2,7);van Langenberg, D.(3,10);Moore, G.T.(5,10);Friedman, A.B.(6);Ding, N.S.(1,7);
Created: Friday, 11 February 2022, 3:52 PM
P320: Accuracy of faecal calprotectin level to select patients with inflammatory bowel disease for a chromoendoscopy surveillance programme
Year: 2018
Source: ECCO '18 Vienna
Authors:

M.L. De Castro1*, A. Lopez-Martínez2, R. Fernandez-Victoria3, L. Sanromán1, J.R. Pineda1, V. Hernández1, J. Martínez-Cadilla1, M. Figueira1, S. Pereira1, I. Rodríguez-Prada1

Created: Thursday, 21 February 2019, 9:14 AM
P320: Clinical and economic effect of short infliximab infusion protocol in patients with inflammatory bowel diseases: a multicentre study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Cappello*1, G. Costantino2, A.C. Privitera3, F. Bossa4, A. Lauria5, L. Grossi6, M. B. Principi7, N. Della Valle8, M. A. Veneziano9, D. Crocchiolo9

Created: Friday, 22 February 2019, 9:49 AM
P320: Combined mesenchymal stromal cells and anti-cytokine therapy of perianal Crohn's disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Knyazev, O.(1,2,3);Kagramanova, A.V.(1);Lishchinskaya, A.(1);Shkurko, T.(4);Li, I.(1);Parfenov, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P320: Confocal Laser Endomicroscopy to predict the efficacy of vedolizumab as first-line biotherapy in ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Quénéhervé, L.(1);Trang-Poisson, C.(2);Fantou, A.(3);Flamant, M.(4);Durand, T.(5);Bouguen, G.(6);Bregeon, J.(7);Oullier, T.(7);Amil, M.(8);Dewitte, M.(6);Bardot, S.(9);Braudeau, C.(10);Josien, R.(3);Neunlist, M.(7);Bourreille, A.(11)*;
Created: Friday, 14 July 2023, 11:05 AM
P320: High Cytomegalovirus DNA load in mucosal biopsies predicts steroid failure as well as colectomy in acute severe ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Jain1, D. Namdeo1, S. Kedia1, P. Sahu1, P. Das1, P. Sahni1, N. R. Dash1, S. Pal1, G. Makharia1, L. Dar1, V. Ahuja*1

Created: Friday, 22 February 2019, 9:41 AM
P320: Utility of a semi-quantitative rapid test in diagnosis of ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Dranga M.*1, Mihai C.1, Gavrilescu O.1, Ungureanu I.1, Cucuteanu B.2, Cijevschi-Prelipcean C.1

Created: Wednesday, 20 February 2019, 10:36 AM
P321 Prognosis of intestinal Behcet’s disease according to the Korean consensus-based diagnostic algorithm
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y.Y. JOO, B.I. Lee, S.J. Kim, H.H. Lee, J.S. Kim, J.M. Park, Y.S. Cho, K.M. Lee, S.W. Kim, H. Choi, M.G. Choi

Created: Thursday, 30 January 2020, 10:12 AM
P321: Activity graph patterns recorded using a mobile monitoring system are associated with clinical outcomes of patients with Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kim E.S.*1, Jang B.I.2, Kim K.O.2, Kim E.Y.3, Lee H.S.1, Kwak S.G.4, Lee E.Y.1, Lee Y.J.5 Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD)

Created: Wednesday, 20 February 2019, 10:36 AM
P321: Cessation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn’s Disease: Individual Patient Data Meta-Analysis of 323 patients from 12 studies
Year: 2021
Source: ECCO'21 Virtual
Authors: Ten Bokkel Huinink, S.(1);van der Woude, J.(1);Casanova, M.J.(2);Bouguen, G.(3);Mak, J.W.Y.(4);Molnar, T.(5);Seidelin, J.(6);Aurelien, A.(7);D'Haens, G.(8);Riviere, P.(9);Guidi, L.(10);Renata, B.(5);Lin, W.C.(11);de Vries, A.(12);
Created: Wednesday, 2 June 2021, 4:12 PM
P321: Increased modified DUBLIN scores are associated with serious ulcerative colitis and treatment failure
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Xie, C.(1)*;Su, J.(1);Liu, L.(1);Lin, Y.(1);Hu, Y.(1);Shi, H.(1);
Created: Friday, 14 July 2023, 11:05 AM
P321: Mucosal Healing and Clinical remission after Treatment with Adalimumab in Small Intestinal Crohn’s Disease (SIMCHA study): final results from a prospective, open-label, single-arm study
Year: 2022
Source: ECCO'22
Authors: Wetwittayakhlang, P.(1);Golovics , P.(1);Hahn, G.(1);Bessissow, T.(1); Afif, W.(1);Wild, G.(1);Bitton, A.(1);LakatosPhD, P.L.(1);
Created: Friday, 11 February 2022, 3:52 PM
P321: Mucosal healing in a cohort of inflammatory bowel diseases paediatric patients in clinical remission
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

F. P. Giugliano1, C. Strisciuglio*2, M. Martinelli1, M. Andreozzi1, S. Cenni1, A. Staiano1, E. Miele1

Created: Friday, 22 February 2019, 9:49 AM
P321: On effectiveness, safety, and TDM of thioguanine in a cohort of 274 patients with IBD, intolerant for conventional thiopurines
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Simsek*1, D. Deben2, C. S. Horjus3, M. Seinen1, C. J. Mulder1, D. R. Wong2, N. K. de Boer1, A. A. van Bodegraven4

Created: Friday, 22 February 2019, 9:41 AM
P321: Ulcerative colitis: Role of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting disease severity
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Jardak1*, M. Medhioub2, K. Agar2, L. Hamzaoui1,2,3, A. Khsiba2, M.M. Azouz2

Created: Thursday, 21 February 2019, 9:14 AM
P322 Impact of the presence of Epstein–Barr virus in intestinal mucosa of inflammatory bowel disease patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. NUÑEZ ORTIZ, C. Trigo Salado, M.D. De la Cruz Ramírez, J.L. Márquez Galán, J.M. Herrera Justiniano, E. Leo Carnerero

Created: Thursday, 30 January 2020, 10:12 AM
P322: A change in ΔMCV predicts mucosal healing in patients with Crohn's disease under combination therapy
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bernardo S., Fernandes S., Correia L., Velosa J.

Created: Wednesday, 20 February 2019, 10:36 AM
P322: Complications to parenteral therapy in patients with intestinal failure because of inflammatory bowel disease: A retrospective cohort study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

R. Lorentsen, L. K. Munck, S. Wildt*

Created: Friday, 22 February 2019, 9:49 AM
P322: Disease-related worries and concerns in patients with ulcerative colitis: 1-year data from ICONIC
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Ghosh*1, F. Casellas2, C. O’Shea3, K. Kligys4, J. Petersson4, L. Peyrin-Biroulet5

Created: Friday, 22 February 2019, 9:41 AM